Our mission and Vision
To prevent and effectively treat
Alzheimer’s disease
The mission of the Alzheimer’s Therapeutic Research Institute (ATRI) is to rigorously test methods for early detection of and treatments for all stages of Alzheimer’s disease (AD) and related dementias.
After decades of work we have reached the most exciting time, where disease-modifying drugs are now available and new possibilities are within reach. We have a vision for the ultimate prevention of AD in the next ten-years.
After decades of work we have reached the most exciting time, where disease-modifying drugs are now available and new possibilities are within reach. We have a vision for the ultimate prevention of AD in the next ten-years.
People
Leadership
Partnerships
Partnerships

Alzheimer's Clinical Trials Consortium
Accelerates the development of effective interventions for Alzheimer’s disease and related disorders by providing optimal infrastructure, utilizes centralized resources and shared expertise,

Alzheimer's Clinical Trials Consortium
Accelerates the development of effective interventions for Alzheimer’s disease and related disorders by providing optimal infrastructure, utilizes centralized resources and shared expertise,
About
Annual Report
2022 may be considered the culmination of three decades of work to develop disease-modifying treatments. Read more in the Alzheimer’s Therapeutic Research Institute annual report, now online.
Take Action
You can make a Difference
Help advance our mission to bring therapeutic advances to our patients and their families.
Making significant progress in fighting one of the most critical public health issues in the country.
Supporting the Alzheimer’s Therapeutic Research Institute (ATRI) helps advance our core mission to bring therapeutic advances to our patients and their families as quickly as possible.